Lymphoma, Primary Effusion: Clinical Trials

19 trials for Lymphoma, Primary Effusion, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

7 completed, 6 recruiting, 3 active not recruiting, 1 not yet recruiting. 9 Phase 2, 7 Phase 1, 2 Not applicable, 1 Early Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	9	Completed 3, Active not recruiting 2, Recruiting 2, Terminated 1, Withdrawn 1
Phase 1	7	Recruiting 3, Completed 2, Active not recruiting 1, Withdrawn 1
Not applicable	2	Completed 2
Early Phase 1	1	Not yet recruiting 1

Follow Lymphoma, Primary Effusion: new trials by email Literature Review of Lymphoma, Primary Effusion trials Research Report on Lymphoma, Primary Effusion

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified	Phase 1	Recruiting	National Cancer Institute (NCI)	15	2027-07-05	2026-10-28
Exploratory Study on the Treatment of EB Virus Positive HIV Associated Lymphoma With EBV mRNA Vaccine EBV mRNA vaccine - HIV Associated Lymphoma	Early Phase 1	Not yet recruiting	West China Hospital	6	2026-05-01	2026-05-01
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease Daratumumab SC - Lymphoma, Primary Effusion	Phase 2	Recruiting	National Cancer Institute (NCI)	40	2024-07-10	2026-10-16
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) EB103 - B-Cell Non-Hodgkin's Lymphoma (NHL), Lymphoma, Non-Hodgkins	Phase 1 / Phase 2	Recruiting	Estrella Immunopharma, Inc.	27	2024-06-01	2026-10-01
Study of SGR-1505 in Mature B-Cell Neoplasms SGR-1505 - Mature B-Cell Neoplasm, Non Hodgkin Lymphoma	Phase 1	Recruiting	Schrödinger, Inc.	98	2023-04-10	2026-02-13
Natural History of KSHV-Associated Multicentric Castleman s Disease Multicentric Castleman s Disease		Recruiting	National Cancer Institute (NCI)	195	2021-11-17	2026-10-16
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 HST-NEETs, Bone Marrow Transplant - HIV Associated Lymphoma	Phase 2	Completed	Catherine Bollard	12	2021-10-25	2026-06-29
Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell Leukemia, Leukemia, Lymphoblastic		Completed	AIDS Malignancy Consortium	35	2021-05-22	2026-10-28
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis Kaposi Sarcoma, KSHV Associated Multicentric Castleman Disease		Active not recruiting	National Cancer Institute (NCI)	40	2021-02-04	2026-08-25
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas Nivolumab, Varlilumab - ALK-Positive Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma Activated B-Cell Type	Phase 2	Active not recruiting	National Cancer Institute (NCI)	54	2018-12-21	2026-10-26
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm	Phase 1 / Phase 2	Active not recruiting	National Cancer Institute (NCI)	17	2017-07-03	2026-10-20
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies XmAb13676 - B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia	Phase 1	Completed	Xencor, Inc.	154	2016-10-01	2024-11-13
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration - Adult Nasal Type Extranodal NK/T-Cell Lymphoma, Adult T-Cell Leukemia/Lymphoma	Not applicable	Completed	Mayo Clinic	29	2016-01-19	2019-11-15
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Pomalidomide, Rituximab, Prednisone - Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma	Phase 1 / Phase 2	Withdrawn	National Cancer Institute (NCI)		2014-08-15	2018-08-31
124I-FIAU Imaging in EBV and KSHV Associated Cancers FIAU-PET-CT-2, FIAU-PET-CT-4 - Hodgkin Lymphoma, Non Hodgkin Lymphoma	Not applicable	Completed	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	12	2010-12-01	2018-09-17
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma	Phase 1 / Phase 2	Completed	National Cancer Institute (NCI)	107	2010-10-06	2023-11-21
Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma carmustine, cyclophosphamide, etoposide - Lymphoma	Phase 2	Completed	Masonic Cancer Center, University of Minnesota	473	2005-08-24	2020-07-14
Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas Pegylated Liposomal Doxorubicin (Doxil) and Rituximab - Non-Hodgkin's Lymphoma, Burkitt Lymphoma	Phase 2	Terminated	University of Southern California	15	2005-04-01	2014-05-22
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer HIV, Kaposi's Sarcoma		Recruiting	National Cancer Institute (NCI)	1029	2000-12-06	2026-10-16

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications

NIH funding